Review ArticleReview
Development of targeted therapies in treatment of glioblastoma
Yuan-Yuan Xu, Pei Gao, Ying Sun and You-Rong Duan
Cancer Biology & Medicine September 2015, 12 (3) 223-237; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0020
Yuan-Yuan Xu
1State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
Pei Gao
1State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
Ying Sun
1State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
You-Rong Duan
1State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China
Article Figures & Data
Figures
In this issue
Development of targeted therapies in treatment of glioblastoma
Yuan-Yuan Xu, Pei Gao, Ying Sun, You-Rong Duan
Cancer Biology & Medicine Sep 2015, 12 (3) 223-237; DOI: 10.7497/j.issn.2095-3941.2015.0020
Jump to section
Related Articles
- No related articles found.
Cited By...
- Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA
- Optical Modulation of Blood-Brain-Tumor Barrier Permeability Enhances Drug Delivery in Diverse Preclinical Glioblastoma Models
- A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses